AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Mivocob P 750mcg/75mg Capsule

Prescription Icon
Prescription Required

Marketer

Avion Healthcare Pvt Ltd

Salt Composition

Methylcobalamin (750mcg) + Pregabalin (75mg)

Overview Mivocob P 750mcg/75mg Capsule

Pregabalin and Naloxone 750mcg/75mg capsules (Mivocob P equivalent) are a prescription medication for neuropathic pain relief. They work by regulating calcium channel function within nerve cells, reducing pain signals. This medication also offers neuroprotective effects and promotes nerve cell repair. Administer orally, with or without food, ideally before sleep, consistently at the same time daily for optimal therapeutic levels. Follow your physician's prescribed dosage and duration precisely, as this medication has addictive potential. If a dose is missed, take it immediately upon recollection. Complete the entire course, regardless of symptom improvement. Abrupt cessation is unsafe and requires medical consultation. Commonly reported side effects include upper respiratory tract infection, increased appetite, elevated mood, trembling, visual blurring, dry mouth, dizziness, and drowsiness. Avoid activities demanding concentration until the medication's effects are understood. These side effects are generally mild and resolve spontaneously. Weight gain is possible; regular exercise and a balanced diet are recommended. Report any unusual mood or behavioral shifts, new or worsening depression, or suicidal ideation to your doctor. Disclose all other medications to your doctor, as interactions can compromise efficacy or alter the medication's action. Inform your doctor about pregnancy, pregnancy planning, or breastfeeding.

Uses of Mivocob P 750mcg/75mg Capsule

Managing neuropathic pain

Major Benefits of Mivocob P 750mcg/75mg Capsule:

Follow your doctor's instructions precisely regarding dosage and treatment length for Mivocob P 750mcg/75mg Capsules. These capsules can be administered with or without food, though consistent timing is recommended.

Common Side effects of Mivocob P 750mcg/75mg Capsule:

  • Sleepiness
  • Dizziness
  • Nasopharyngitis (inflammation of the throat and nasal passages)
  • Increased appetite
  • Blurred vision
  • Constipation
  • Muscle cramp
  • Edema (swelling)
  • Erectile dysfunction
  • Weight gain
  • Balance disorder (loss of balance)
  • Lethargy
  • Vertigo
  • Vomiting
  • Headache
  • Confusion
  • Disorientation
  • Abnormality of voluntary movements

How to use Mivocob P 750mcg/75mg Capsule:

Follow your doctor's instructions precisely regarding dosage and treatment length for Mivocob P 750mcg/75mg Capsules. These capsules can be administered with or without food, although consistent timing is recommended.

How Mivocob P 750mcg/75mg Capsule works:

Each Mivocob P 750mcg/75mg capsule unites methylcobalamin (a vitamin B variant) with pregabalin. Methylcobalamin aids myelin production, safeguarding nerve fibers and promoting nerve cell repair. Pregabalin, acting as an alpha-2-delta ligand, alleviates pain by regulating nerve cell calcium channel function. This dual action provides relief from neuropathic pain stemming from nerve damage.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Mivocob P 750mcg/75mg capsules and alcohol can lead to increased sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Mivocob P 750mcg/75mg Capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Seek medical advice before using this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Mivocob P 750mcg/75mg Capsules while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Taking Mivocob P 750mcg/75mg Capsules might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.

KidneyKidneyCAUTION

Patients with kidney impairment should use Mivocob P 750mcg/75mg Capsules cautiously, as dose modification may be necessary. Physician consultation is advised.

LiverLiverSAFE IF PRESCRIBED

The use of Mivocob P 750mcg/75mg Capsule in individuals with liver impairment is likely safe. Available evidence indicates dose modification may not be necessary, but physician consultation is recommended.

What if you forget to take Mivocob P 750mcg/75mg Capsule :

Should you forget to take a Mivocob P 750mcg/75mg Capsule, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Mivocob P 750mcg/75mg Capsule

LabelValue
Potential for Dependence None.
Type of Medication Nervous system medications

FAQs on Mivocob P 750mcg/75mg Capsule

Pregabalin and methylcobalamin, combined as Mivocob P 750mcg/75mg Capsule, provide relief from nerve pain (neuropathic pain). This medication works by modulating brain activity to soothe damaged or hyperactive nerves, thus reducing pain perception. Additionally, it promotes the repair of damaged nerve tissue.
Discontinuing Mivocob P 750mcg/75mg Capsules, even with pain relief, is inadvisable. Follow your physician's prescribed dosage. Abrupt cessation may induce withdrawal effects including anxiety, insomnia, nausea, pain, and diaphoresis. A gradual reduction in Mivocob P 750mcg/75mg Capsule usage is recommended prior to complete discontinuation.
Taking Mivocob P 750mcg/75mg Capsules may increase appetite, potentially leading to weight gain. Preventing this weight gain is simpler than subsequent weight loss. Maintain a nutritious, balanced diet without enlarging portions. Limit high-calorie foods like sugary drinks, fried foods, processed snacks, and desserts. Between meals, choose fruits, vegetables, and low-calorie options instead of unhealthy snacks. Regular physical activity aids in preventing weight gain. A combination of healthy eating and exercise may prevent any weight increase.
Using Mivocob P 750mcg/75mg Capsules can cause drowsiness or sudden sleep onset during normal activities. These episodes may occur without prior warning signs of drowsiness. Refrain from driving, operating equipment, working at heights, or engaging in hazardous tasks, especially at treatment initiation, until the drug's effects are known. Report any such occurrences to your physician during treatment.
Mivocob P 750mcg/75mg Capsule rarely produces severe adverse reactions. Nonetheless, serious side effects such as allergic reactions, suicidal ideation, or limb edema (hands, feet, or legs) are possible. Discontinue Mivocob P 750mcg/75mg Capsule and seek immediate medical attention if any of these occur. Allergic reactions manifest as facial, oral, lip, gum, tongue, or neck swelling, and may include respiratory distress, skin rashes, urticaria (hives), or blisters. Monitor for any abrupt shifts in mood, behavior, thinking, or feelings, including the emergence of suicidal thoughts.
Patients may experience initial improvements with Mivocob P 750mcg/75mg Capsules within two weeks. Complete therapeutic effects, however, might require two to three months, or longer in certain cases.
Should you miss a dose of Mivocob P 750mcg/75mg Capsule, and your next dose is imminent, omit the missed dose and proceed with your regular schedule. If your next dose is not soon, take the missed dose immediately upon recollection, then resume your usual medication regimen. Avoid doubling your dose to compensate for a missed one, as this can heighten the likelihood of adverse reactions. In case of uncertainty, seek guidance from your physician regarding appropriate action.
Exceeding the prescribed dosage won't necessarily enhance efficacy; instead, it could heighten the risk of severe adverse reactions and toxicity. Should your symptoms worsen despite adhering to the recommended dosage, seek medical advice for reassessment.
Refrain from consuming alcohol during your Mivocob P 750mcg/75mg Capsule treatment. Alcohol may worsen the somnolence induced by this medication.
Regular check-ups with your physician are advisable following initiation of Mivocob P 750mcg/75mg Capsule treatment. Consult your doctor immediately if your symptoms don't improve with the prescribed dosage or if you encounter adverse reactions impacting your daily life.
Maintain the tablets within their original packaging until needed. Store in a cool, dry environment. Keep out of the reach and sight of children. Dispose of any leftover medication using appropriate methods to prevent accidental ingestion by children, pets, or others.
Mivocob P 750mcg/75mg Cap...
121
MRP 148
18% off